Authorized Generics In Spotlight At Senate Hearing

Law360, New York (April 11, 2007, 12:00 AM EDT) -- Despite suffering a defeat in the Schering-Plough case, the Federal Trade Commission intends to continue fighting authorized generics agreements and has vowed to make its crackdown on so-called reverse payments one of the agency’s top priorities in the coming year.

On Tuesday, FTC Commissioner Deborah Majoras, flanked by fellow Commissioners Harbour, Leibowitz, Kovacic and Rosch, testified before the Senate Committee on Commerce, Science and Transportation, pleading for an increase in the agency’s budget.

The Commissioners are seeking $240 million for fiscal year 2008, a markup of...
To view the full article, register now.